The Obama Administration releases the first comprehensive National HIV/AIDS Strategy for the United States setting specific goals in reducing HIV infections, increasing access to care and treatment, impacting health disparities, and improving coordination of efforts across federal agencies.
The iPrEx study finds a daily dose of HIV drugs reduced the risk of HIV infection among HIV-negative men who have sex with men by 44%, supporting the concept of pre-exposure prophylaxis (PrEP).